WRN promoter methylation possibly connects mucinous differentiation, microsatellite instability and CpG island methylator phenotype in colorectal cancer

被引:31
|
作者
Kawasaki, Takako [1 ,2 ]
Ohnishi, Mutsuko [2 ]
Suemoto, Yuko [2 ]
Kirkner, Gregory J. [1 ,3 ]
Liu, Zhiqian [2 ]
Yamamoto, Hiroyuki [4 ]
Loda, Massimo [1 ,2 ]
Fuchs, Charles S. [1 ,2 ,3 ]
Ogino, Shuji [1 ,2 ]
机构
[1] Harvard Univ, Brigham & Womens Hosp, Dept Pathol, Sch Med, Boston, MA 02115 USA
[2] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA
[3] Brigham & Womens Hosp, Channing Lab, Dept Med, Boston, MA USA
[4] Sapporo Med Univ, Dept Internal Med 1, Sapporo, Hokkaido, Japan
关键词
colon cancer; WRN; mucin; DNA methylation; CIMP; MSI;
D O I
10.1038/modpathol.3800996
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Werner syndrome is a premature aging syndrome characterized by early onset of cancer and abnormal cellular metabolism of glycosaminoglycan. The WRN helicase plays an important role in the maintenance of telomere function. WRN promoter methylation and gene silencing are common in colorectal cancer with the CpG island methylator phenotype (CIMP), which is associated with microsatellite instability (MSI) and mucinous tumors. However, no study has examined the relationship between mucinous differentiation, WRN methylation, CIMP and MSI in colorectal cancer. Utilizing 903 population-based colorectal cancers and real-time PCR (MethyLight), we quantified DNA methylation in WRN and eight other promoters (CACNA1G, CDKN2A, CRABP1, IGF2, MLH1, NEUROG1, RUNX3 and SOCS1) known to be specific for CIMP. Supporting WRN as a good CIMP marker, WRN methylation was correlated well with CIMP-high diagnosis (>= 6/8 methylated promoters), demonstrating 89% sensitivity and 81% specificity. WRN methylation was associated with the presence of any mucinous component and >= 50% mucinous component (P<0.0001). Because both MSI and CIMP were associated with mucinous tumors and WRN methylation, we stratified tumors into 9 MSI/CIMP subtypes, to examine whether the relationship between WRN methylation and mucin still persisted. In each MSI/CIMP subtype, tumors with mucinous component were persistently more common in WRN-methylated tumors than WRN-unmethylated tumors (P=0.004). No relations of WRN methylation with other variables (age, sex, tumor location, poor differentiation, signet ring cells, lymphocytic reactions, KRAS, BRAF, p53, p21 or 18q loss of heterozygosity) persisted after tumors were stratified by CIMP status. In conclusion, WRN methylation is associated with mucinous differentiation independent of CIMP and MSI status. Our data suggest a possible role of WRN methylation in mucinous differentiation, and may provide explanation to the enigmatic association between mucin and MSI/CIMP.
引用
收藏
页码:150 / 158
页数:9
相关论文
共 50 条
  • [1] IGFBP3 promoter methylation in colorectal cancer:: Relationship with microsatellite instability, CpG island methylator phenotype, and p53
    Kawasaki, Takako
    Nosho, Katsuhiko
    Ohnishi, Mutsuko
    Suemoto, Yuko
    Kirknery, Gregory J.
    Fuchs, Charles S.
    Ogino, Shuji
    [J]. NEOPLASIA, 2007, 9 (12): : 1091 - 1098
  • [2] The impact of CpG island methylator phenotype and microsatellite instability on tumour budding in colorectal cancer
    Zlobec, Inti
    Bihl, Michel P.
    Foerster, Anja
    Rufle, Alex
    Lugli, Alessandro
    [J]. HISTOPATHOLOGY, 2012, 61 (05) : 777 - 787
  • [3] Impact of CpG island methylator phenotype and microsatellite instability on tumor budding in colorectal cancer
    Zlobec, I.
    Bihl, M.
    Koelzer, V.
    Foerster, A.
    Rufle, A.
    Lugli, A.
    [J]. VIRCHOWS ARCHIV, 2011, 459 : S19 - S20
  • [4] Tetranucleotide and Low Microsatellite Instability Are Inversely Associated with the CpG Island Methylator Phenotype in Colorectal Cancer
    Meessen, Sabine
    Currey, Nicola
    Jahan, Zeenat
    Parker, Hannah W.
    Jenkins, Mark A.
    Buchanan, Daniel D.
    Hopper, John L.
    Segelov, Eva
    Dahlstrom, Jane E.
    Kohonen-Corish, Maija R. J.
    [J]. CANCERS, 2021, 13 (14)
  • [5] BRAF mutation, CpG island methylator phenotype and microsatellite instability occur more frequently and concordantly in mucinous than non-mucinous colorectal cancer
    Tanaka, H
    Deng, GR
    Matsuzaki, K
    Kakar, S
    Kim, GE
    Miura, S
    Sleisenger, MH
    Kim, YS
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2006, 118 (11) : 2765 - 2771
  • [6] The Role of the CpG Island Methylator Phenotype in Colorectal Cancer Prognosis Depends on Microsatellite Instability Screening Status
    Dahlin, Anna M.
    Palmqvist, Richard
    Henriksson, Maria L.
    Jacobsson, Maria
    Eklof, Vincy
    Rutegard, Jorgen
    Oberg, Ake
    Van Guelpen, Bethany R.
    [J]. CLINICAL CANCER RESEARCH, 2010, 16 (06) : 1845 - 1855
  • [7] CpG island methylator phenotype in colorectal cancer
    Toyota, M
    Ahuja, N
    Ohe-Toyota, M
    Herman, JG
    Baylin, SB
    Issa, JPJ
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (15) : 8681 - 8686
  • [8] The CpG island methylator phenotype in colorectal cancer
    Samowitz, Wade S.
    [J]. JOURNAL OF MOLECULAR DIAGNOSTICS, 2007, 9 (03): : 281 - 283
  • [9] Association of Chromosomal Instability, Microsatellite Instability and CPG Island Methylator Phenotype with Postcolonoscopy Colorectal Cancer in a Population Based Study
    Bogie, R. M. M.
    le Clercq, C. M. C.
    Voorham, Q. J. M.
    Cordes, M.
    Sie, D.
    Rausch, C.
    van den Broek, E.
    de Vries, S. D. J.
    van Grieken, N. C. T.
    Riedl, R. G.
    Sastrowijoto, P.
    van Engeland, M.
    Ylstra, B.
    Meijer, G. A.
    Masclee, A. A. M.
    Carvalho, B.
    Sanduleanu, S.
    [J]. JOURNAL OF PATHOLOGY, 2018, 246 : S31 - S31
  • [10] PTGER2 Overexpression in Colorectal Cancer Is Associated with Microsatellite Instability, Independent of CpG Island Methylator Phenotype
    Baba, Yoshifumi
    Nosho, Katsuhiko
    Shima, Kaori
    Goessling, Wolfram
    Chan, Andrew T.
    Ng, Kimmie
    Chan, Jennifer A.
    Giovannucci, Edward L.
    Fuchs, Charles S.
    Ogino, Shuji
    [J]. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2010, 19 (03) : 822 - 831